Asia
The azithromycin market in the Asian region demonstrated a fluctuating pattern during the said period. Initially, the market maintained stable prices with a gradual upward movement due to consistent exports. The supply situation remained balanced, though logistics challenges and elevated freight charges contributed to increased operational costs.
Suppliers successfully passed these additional expenses to consumers due to the positive market sentiment. However, prices began declining towards the quarter's end as manufacturers focused on destocking activities, leading to increased market availability. Simultaneously, the terminal demand weakened, further contributing to the softening azithromycin prices in the final weeks of the quarter.
Europe
Azithromycin prices in Europe exhibited an oscillating trajectory throughout Q3’24. The market initially experienced upward momentum, supported by steady pharmaceutical sector demand and improved consumer sentiment due to easing inflation rates. Despite high logistics costs providing some upward pressure, the market witnessed a significant shift in dynamics towards the latter part of the quarter. The prices registered a downturn as demand fundamentals weakened considerably, prompting suppliers to adjust their pricing strategies.
North America
The US domestic market exhibited a mixed pricing trend during Q3’24. The period began with firm prices supported by positive consumer sentiment and supply chain constraints. Logistical challenges, including port congestion and vessel rerouting, created supply tightness that bolstered prices. However, the market momentum shifted as the quarter progressed, with prices declining due to weakening demand fundamentals and growing economic uncertainties.